Seres Therapeutics (MCRB) Receivables - Net (2016 - 2026)
Seres Therapeutics (MCRB) posted Receivables - Net of $233000.0 for Q1 2026, up 48.41% sequentially from $157000.0 in Q4 2025, and down 96.85% YoY from $7.4 million in Q1 2025.
Seres Therapeutics (MCRB) Receivables - Net (2016 - 2026) Analysis & Trends
Seres Therapeutics has reported Receivables - Net for 9 years, with the latest figure at $233000.0 in Q1 2026.
- Quarterly Receivables - Net fell 96.85% year-over-year to $233000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $233000.0 (down 96.85% YoY) and the FY2025 annual result came in at $14.9 million, up 300.03% from the prior year.
- Receivables - Net climbed to $233000.0 in Q1 2026 per MCRB's latest filing, from $157000.0 in the prior quarter.
- Over five years, Receivables - Net peaked at $7.4 million in Q1 2025 and troughed at $157000.0 in Q4 2025.
- A 3-year average of $2.4 million and a median of $351000.0 in 2025 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2025 and 2026: Receivables - Net plunged 95.78% in 2025, then tumbled 96.85% in 2026.
- Over 3 years, Receivables - Net stood at $3.7 million in 2024, then slumped by 95.78% to $157000.0 in 2025, then jumped by 48.41% to $233000.0 in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $233000.0, $157000.0, and $351000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.51 Bn | 78.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.74 Bn | 60.56 Bn | 1.37 Bn |
| 4 | Moderna | 59.39 Bn | 54.26 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.78 Bn | 28.47 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.39 Bn | - |
| 10 | Seres Therapeutics | 44.26 Mn | 44.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 274,000.00 |
| Jun 30, 2026 | 274,000.00 |
| Mar 31, 2026 | 233,000.00 |
| Mar 31, 2026 | 233,000.00 |
| Dec 31, 2025 | 157,000.00 |
| Dec 31, 2025 | 157,000.00 |
| Sep 30, 2025 | 351,000.00 |
| Sep 30, 2025 | 351,000.00 |
| Mar 31, 2025 | 7.40 Mn |
| Mar 31, 2025 | 7.40 Mn |
| Dec 31, 2024 | 3.72 Mn |
| Dec 31, 2024 | 3.72 Mn |
| Sep 30, 2021 | 1.25 Mn |
| Sep 30, 2021 | 1.25 Mn |
| Jun 30, 2021 | 1.25 Mn |
| Jun 30, 2021 | 1.25 Mn |
| Mar 31, 2021 | 2.60 Mn |
| Mar 31, 2021 | 2.60 Mn |
| Dec 31, 2020 | 9.39 Mn |
| Dec 31, 2020 | 9.39 Mn |